Cat.#: ACPP-1581
Despition | FGF 9 Rat Recombinant |
SIZE | 2 µg |
Purity | > 95.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
ACPP-1420 | MOG (AC1420) | 5 mg | inquiry |
ACPP-1717 | Mouse LIF Protein (AC1717) | 3 x 2 µg | inquiry |
ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
ACPP-1035 | Recombinant Mouse TNF Receptor II Protein (6×His Tag) (AC1035) | 50 µg | inquiry |
ACPP-1137 | Recombinant HuD Antigen (AC1137) | 100 µg | inquiry |
ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.